Can low protein-energy availability reduce neurotransmitter precursors and stress resilience?

Low protein-energy availability—whether from sustained under-fueling, restrictive dieting, or more severe protein-energy malnutrition—can affect both neurochemical precursor supply and multisystem capacity to meet physiological demands. The overall claim is supported with moderate confidence, although the most direct evidence concerns circulating amino acids and systemic consequences rather than brain neurotransmitter measurements or a single validated “resilience” endpoint.

Neurotransmitter-precursor evidence

• In a 2-week randomized very-low-calorie diet study, plasma tryptophan declined 21%, kynurenine 16%, and phenylalanine also fell significantly. A 500-kcal/day formula diet reduced tryptophan and the tryptophan:large-neutral-amino-acid ratio.
• Tryptophan is required for serotonin synthesis; tyrosine and phenylalanine contribute to dopamine and norepinephrine synthesis. Brain tryptophan transport depends particularly on its ratio to competing large neutral amino acids, making the observed ratio reduction mechanistically relevant.
• Acute experimental precursor-depletion paradigms show that marked tryptophan reductions reduce central serotonin synthesis/turnover. However, plasma changes during real-world protein-energy restriction do not by themselves demonstrate lower brain monoamine concentrations; tyrosine was unchanged in one randomized very-low-calorie study.

Physiological resilience and mechanisms

• Problematic low energy availability is associated with an energy-conservation phenotype: lower T3, leptin, insulin, and IGF-1, increased cortisol, and growth-hormone resistance, with cardiovascular, immune, neuromuscular, and psychological abnormalities.
• Greater respiratory and gastrointestinal infections have been reported. In more severe protein-energy malnutrition, immune deficiency, impaired wound healing, reduced lean and cardiac muscle, fatigue, and hypothermia provide concrete pathways through which recovery from illness, injury, exertion, or other stressors may be compromised.
• The IOC’s 2023 REDs Clinical Assessment Tool accordingly treats problematic low energy availability as a physician-led, multisystem clinical diagnosis rather than a condition defined by one intake threshold.

Bottom line

• Low protein-energy availability can reduce monoamine precursor availability—most clearly tryptophan—and can impair physiological stress tolerance through broad endocrine, metabolic, immune, and functional effects. The neurochemical pathway is biologically credible, but direct evidence of reduced brain neurotransmitter production from ordinary dietary restriction remains limited.